These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9024186)

  • 1. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
    Donaldson JA; Glauser TA; Olberding LS
    Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures.
    Tjia-Leong E; Leong K; Marson AG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007783. PubMed ID: 21154386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.
    Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W
    Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine therapy of epilepsy in tuberous sclerosis.
    Franz DN; Tudor C; Leonard J; Egelhoff JC; Byars A; Valerius K; Sethuraman G
    Epilepsia; 2001 Jul; 42(7):935-40. PubMed ID: 11488895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
    Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
    Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lamotrigine in refractory partial and general epilepsies].
    Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
    Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.